Two prominent congressional Democrats this week wrote to eight pharmaceutical company CEOs, urging them to remove 130 patents ...
The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to the United States Department of Health and Human Services. Some federal ...
The average drug price increase from 2022 to 2023 was 15%, according to the United States Department of Health and Human Services. The Federal Trade Commission says drug makers are gaming the system ...
Gabriel: If drug manufacturers don’t remove their junk patent listings, they’ll open themselves up to antitrust lawsuits, and those can be pretty expensive. But the FTC hasn’t announced if ...
Although drug manufacturers have steadily increased the number of patents on their products over the past few decades, they have largely evaded government pushback—until now. The Federal Trade ...
Related: FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers The committee already has passed several bipartisan bills targeting "pay-for-delay" agreements, in which ...
It’s hard to find bipartisan consensus among lawmakers in Congress these days. But there’s widespread agreement on calls for pharmaceutical patent reform. The steep prices of brand-name drugs ...
Outrage from legions of Beyoncé and Taylor Swift fans about hidden concert ticket fees helped spark a national conversation around “junk fees." It has even filtered into the 2024 election cycle.
“[R]egulators may not care what the ostensible goal of a conspiracy is if they think it might harm competition. Indeed, the law generally does not recognize health and safety as justifications ...